Research Article

Prevalence of Antimicrobial Resistance of Common Bacterial Isolates Before and During COVID-19 Pandemic in Armed Forces Hospital Jazan, Saudi Arabia

Manal AlDiba
Armed Forces Hospital Jazan, Saudi Arabia
Ahmad Mohammad Hassan Daghriri
Armed Forces Hospital Jazan, Saudi Arabia
Essa Mohammed Essa Jamali
Armed Forces Hospital Jazan, Saudi Arabia
Ahmed Alzahrani
Armed Forced Hospital, Saudi Arabia
Ahmed Bijad Alsharif
Armed Forces Hospital Jazan, Saudi Arabia
Haider Ghalip Almudeer
Armed Forces Hospital Jazan, Saudi Arabia
Hassan Khobrani
Armed Forces Hospital Jazan, Saudi Arabia
Nabil Turki Madhi Hakami
Armed Forces Hospital Jazan, Saudi Arabia
Wagih Mommtaz Ghannam
Mansoua University, Egypt
* Corresponding author
Hassan Mohamed Alasy
Tanta University, Egypt
DOI icon 10.24018/ejmed.2021.3.5.1047

Read Counter
1211

Downloads
731

Citations

Share

Article Sidebar

Submitted 2021-09-05
Published 2021-09-29

Read counter = 1211 times

Table of Contents

Article Main Content

Background: Antimicrobial resistance (AMR) is one of the top global public health issues. After the pandemic of corona virus 2019 (COVID-19), AMR became a challenging complex that needs to be addressed during the corona pandemic.

Objectives: Evaluating the prevalence of antimicrobial resistance (AMR) before and during COVID-19 pandemic.

Methods: This is a retrospective cross-sectional study that was conducted at Armed Forces Hospital Jazan, Saudi Arabia using positive cultures` results from microbiology department.

Results: Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Klebsiella pneumoniae were the most prevalent microorganisms isolated from the patients. E. coli was the most isolated organism from patients with infections such as: COVID-19 fever, sepsis, urinary tract infections and wound infection. There was no significant change between 2019 and 2020 regarding AMR prevalence.

Conclusion: There was no significant difference in the AMR before and during the COVID-19 era thus other large population studies must be conducted to evaluate worldwide evolution of AMR during COVID-19 pandemic.

Keywords: Antimicrobial resistance, COVID-19 pandemic, antibiotics, corona virus critical illness, drug resistance, Urinary tract infection, sepsis ,KSA.

References

  1. M. Dryden, A. P. Johnson, D. Ashiru-Oredope and M. Sharland, "Using antibiotics responsibly: right drug, right time, right dose, right duration," The Journal of Antimicrobial Chemotherapy 66(11):2441-3, 2011. doi:10.1093/jac/dkr370.
     Google Scholar
  2. T. M. Rawson, D. Ming, R. Ahmad, L. S. P. Moore and A. H. Holmes, "Antimicrobial use, drug-resistant infections and COVID-19," Nature Reviews Microbiology 18(8):409-10, 2020. doi:10.1038/s41579-020-0395-y.
     Google Scholar
  3. T. M. Rawson, L. S. P. Moore, E. Castro-Sanchez, E. Charani, F. Davies, G. Satta and A. H. Holmes, "COVID-19 and the potential long-term impact on antimicrobial resistance," The Journal of Antimicrobial Chemotherapy. 75(7):1681-4, 2020. doi:10.1093/jac/dkaa194.
     Google Scholar
  4. M. A. B. Lucien, M. F. Canarie, P. E. Kilgore, G. Jean-Denis, N. Fénélon, M. Pierre, and B. Roman Pardo, "Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings," International journal of infectious diseases 104:250-4, 2021. doi:10.1016/j.ijid.2020.12.087.
     Google Scholar
  5. D. L. Monnet and S. Harbarth "Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?" Euro Surveill 25(45):2001886, 2020. doi:10.2807/1560-7917.ES.2020.25.45.2001886.
     Google Scholar
  6. D. van Duin, G. Barlow and D. Nathwani, "The impact of the COVID-19 pandemic on antimicrobial resistance: a debate," JAC Antimicrob Resist 2(3):dlaa053-dlaa, 2020. doi:10.1093/jacamr/dlaa053.
     Google Scholar
  7. R. Kohlmann and S. G. Gatermann, "Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data--The Influence of Different Parameters in a Routine Clinical Microbiology Laboratory," PloS one 11(1):e0147965-e, 2016. doi:10.1371/journal.pone.0147965.
     Google Scholar
  8. CLSI.Performance standards for Antimicrobial Susceptibility Testing.31st ed. CLSI supplement M100. Clinical and laboratory standards Institute;2021.
     Google Scholar
  9. H. O. Ukuhor, "The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics," J Infect Public Health 14(1):53-60, 2021.
     Google Scholar
  10. L. Fattorini, R. Creti, C. Palma and A. Pantosti, "Bacterial coinfections in COVID-19: an underestimated adversary," 56:359-64, 2020. doi: 10.4415/ANN_20_03_14.
     Google Scholar
  11. L. Lansbury, B. Lim, V. Baskaran and W. S. Lim, "Co-infections in people with COVID-19: a systematic review and meta-analysis," Journal of Infection 81(2):266-75, 2020.
     Google Scholar
  12. B. Gasperini, A. Cherubini, M. Lucarelli, E. Espinosa and E. Prospero, "Multidrug-Resistant Bacterial Infections in Geriatric Hospitalized Patients before and after the COVID-19 Outbreak: Results from a Retrospective Observational Study in Two Geriatric Wards," Antibiotics 10(1), 95, 2021. doi:10.3390/antibiotics10010095.
     Google Scholar